Neuroimaging Study on the Effect of Transdermal Buprenorphine in Complex Regional Pain Syndrome Patients

NCT03977012 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2023-04-14

No results posted yet for this study

Summary

In the present study, we aim to investigate the effect of buprenorphine on neuroinflammation in patients with complex regional pain syndrome, using \[11C\]-(R)-PK11195 PET.

Conditions

  • Complex Regional Pain Syndromes

Interventions

DRUG

Buprenorphine

5\~20 mcg

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-11
Primary Completion
2024-04-01
Completion
2024-05-01

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03977012 on ClinicalTrials.gov